Nu Skin (NUS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Nu Skin Enterprises NYSE: NUS reported first-quarter 2026 results that management said were in line with expectations, as the company continued to invest in its Prysm iO wellness platform and emerging-market expansion while navigating macroeconomic pressures on consumers and supply chains.
Nu Skin Enterprises, Inc. (NUS) Q1 2026 Earnings Call Transcript
| Household Products Industry | Consumer Staples Sector | Ryan S. Napierski CEO | XMIL Exchange | US67018T1051 ISIN |
| US Country | 2,800 Employees | 29 May 2026 Last Dividend | - Last Split | 21 Nov 1996 IPO Date |
Nu Skin Enterprises, Inc. is a multinational corporation that has carved its niche in the development and distribution of premium beauty and wellness products on a global scale. Since its inception in 1984, the company has been at the forefront of offering innovative skin care devices, cosmetics, personal care products, and wellness supplements. Headquartered in Provo, Utah, Nu Skin leverages a unique business model, distributing its wide array of products through a combination of retail channels, its website, digital platforms, and a network of independent direct sellers and marketers. Additionally, it places a strong emphasis on research and product development, particularly in the realms of skin care and nutritional supplements, underlining its commitment to quality and efficacy.
Under its umbrella, Nu Skin Enterprises, Inc. markets a diverse range of products across various brands, each designed to cater to specific beauty and wellness needs:
In addition to offering these products under the Nu Skin, Pharmanex, and ageLOC brands, the company remains dedicated to pushing the boundaries of what's possible in skin care and nutrition through ongoing research and development efforts.